CRS
Overvalued by 100.9% based on the discounted cash flow analysis.
Market cap | $3.90 Billion |
---|---|
Enterprise Value | $4.59 Billion |
Dividend Yield | $0.7961 (1.01%) |
Earnings per Share | $2.88 |
Beta | 1.39 |
Outstanding Shares | 49,412,387 |
Avg 30 Day Volume | 500,327 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 27.2 |
---|---|
PEG | 4.55 |
Price to Sales | 1.44 |
Price to Book Ratio | 2.74 |
Enterprise Value to Revenue | 1.68 |
Enterprise Value to EBIT | 19.04 |
Enterprise Value to Net Income | 32 |
Total Debt to Enterprise | 0.15 |
Debt to Equity | 0.48 |
No data
No data